MEG | ||
---|---|---|
OUTLOOK RATING 1..100 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 90 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EPHE | MEG | |
---|---|---|
RSI ODDS (%) | 2 days ago77% | 2 days ago73% |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago90% |
Momentum ODDS (%) | 2 days ago80% | 2 days ago86% |
MACD ODDS (%) | 2 days ago75% | 2 days ago73% |
TrendWeek ODDS (%) | 2 days ago83% | 2 days ago80% |
TrendMonth ODDS (%) | 2 days ago81% | 2 days ago80% |
Advances ODDS (%) | 15 days ago78% | 3 days ago77% |
Declines ODDS (%) | 2 days ago83% | 8 days ago78% |
BollingerBands ODDS (%) | 2 days ago82% | 2 days ago86% |
Aroon ODDS (%) | 2 days ago79% | 2 days ago81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SLSSX | 12.15 | -0.04 | -0.33% |
Selected International S | |||
PNAIX | 76.13 | -0.26 | -0.34% |
T. Rowe Price All-Cap Opportunities-I | |||
ESECX | 31.57 | -0.13 | -0.41% |
Eaton Vance Atlanta Capital Sel Eq C | |||
MVGLX | 16.82 | -0.07 | -0.41% |
MFS Low Volatility Global Equity R3 | |||
USLYX | 81.41 | -0.44 | -0.54% |
JHancock U.S. Global Leaders Growth R2 |
A.I.dvisor tells us that EPHE and TEL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPHE and TEL's prices will move in lockstep.
Ticker / NAME | Correlation To EPHE | 1D Price Change % | ||
---|---|---|---|---|
EPHE | 100% | -1.51% | ||
TEL - EPHE | 29% Poorly correlated | -1.33% | ||
AGI - EPHE | 27% Poorly correlated | -0.16% | ||
PCOR - EPHE | 22% Poorly correlated | +2.23% | ||
MEG - EPHE | 19% Poorly correlated | -3.10% | ||
AP - EPHE | 9% Poorly correlated | -4.41% | ||
More |